New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. AZN
5. ROIV
6. AAPL
7. ACN
8. USO
9. ORCL
10. HOOD

Go back to New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1
(NYSE: TAK) Delayed: 18.34 -0.11 (0.6%)
Previous Close $18.45    52 Week High $0.55 
Open $18.53    52 Week Low $0.55 
Day High $18.65    P/E N/A 
Day Low $18.32    EPS $-0.20 
Volume 847,440